| scholarly article | Q13442814 |
| P50 | author | John H. White | Q30512605 |
| Benjamin Lallemant | Q72795770 | ||
| Sylvie Mader | Q91322414 | ||
| David Laperrière | Q120397932 | ||
| P2093 | author name string | Rui Zhang | |
| Tian-Tian Wang | |||
| Eric Libby | |||
| Veronique Bourdeau | |||
| Yoshihiko Nagai | |||
| Anna Konstorum | |||
| Luz Elisa Tavera-Mendoza | |||
| Naomi Burton MacLeod | |||
| P433 | issue | 11 | |
| P921 | main subject | in silico | Q192572 |
| P304 | page(s) | 2685-2695 | |
| P577 | publication date | 2005-07-07 | |
| P1433 | published in | Molecular Endocrinology | Q3319475 |
| P1476 | title | Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes | |
| P478 | volume | 19 |
| Q33523626 | 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1. |
| Q47801198 | 1,25-Dihydroxyvitamin D Regulation of Glutamine Synthetase and Glutamine Metabolism in Human Mammary Epithelial Cells |
| Q28287569 | 1,25-Dihydroxyvitamin D and 25-hydroxyvitamin D--mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco-2 cells |
| Q34477944 | 1,25-Dihydroxyvitamin D3 promotes a sustained LPS-induced NF-κB-dependent expression of CD55 in human monocytic THP-1 cells |
| Q53562423 | 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB. |
| Q36462037 | 1,25D3 prevents CD8(+)Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter |
| Q54563363 | 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. |
| Q33556370 | 1α, 25-Dihydroxyvitamin D regulates hypoxia-inducible factor-1α in untransformed and Harvey-ras transfected breast epithelial cells |
| Q36298643 | 1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial. |
| Q39165834 | 1α,25-dihydroxyvitamin D3 stimulates activin A production to fine-tune osteoblast-induced mineralization. |
| Q34717974 | 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells |
| Q50937371 | A genomewide association study identified CYP2J2 as a gene controlling serum vitamin D status in beef cattle. |
| Q46358328 | A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP). |
| Q27346674 | Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness |
| Q27011921 | Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV |
| Q33513312 | Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down |
| Q58779190 | Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors |
| Q35585386 | Antitumor effects of vitamin D analogs on hamster and mouse melanoma cell lines in relation to melanin pigmentation |
| Q36302600 | Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies |
| Q37101299 | Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL. |
| Q38814749 | Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients |
| Q39114123 | Association of vitamin D receptor FokI and ApaI polymorphisms with lung cancer risk in Tunisian population |
| Q36027309 | Association of vitamin D receptor gene polymorphisms and vitamin D levels with asthma and atopy in Cypriot adolescents: a case-control study |
| Q38255387 | Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies |
| Q33484938 | Association study between vitamin D receptor gene polymorphisms and asthma in the Chinese Han population: a case-control study |
| Q21284419 | Asthma and genes encoding components of the vitamin D pathway |
| Q21284412 | Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway |
| Q34386686 | Autocrine and paracrine actions of vitamin d |
| Q37726327 | Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates |
| Q39386469 | CYP24 inhibition preserves 1α,25-dihydroxyvitamin D(3) anti-proliferative signaling in lung cancer cells. |
| Q41808231 | Calcitriol and TO-901317 interact in human prostate cancer LNCaP cells |
| Q36353718 | Calcitriol modulates the CD46 pathway in T cells |
| Q45367779 | Cancer, sunlight and vitamin D. |
| Q43188280 | Cellular zinc homeostasis is a regulator in monocyte differentiation of HL-60 cells by 1 alpha,25-dihydroxyvitamin D3. |
| Q33784002 | Chlamydial infection in vitamin D receptor knockout mice is more intense and prolonged than in wild-type mice |
| Q90005543 | Cholecalciferol (Vitamin D3) Reduces Rat Neuropathic Pain by Modulating Opioid Signaling |
| Q36892472 | Cholecalciferol (vitamin D₃) improves myelination and recovery after nerve injury |
| Q64117691 | Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients |
| Q24633922 | Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease |
| Q36596915 | Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer |
| Q33270387 | Computational promoter analysis of mouse, rat and human antimicrobial peptide-coding genes |
| Q36638670 | Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis |
| Q36414495 | Coordinated control of renal Ca2+ handling |
| Q42032248 | Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength |
| Q39106107 | Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system. |
| Q37286643 | Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells |
| Q39992429 | DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. |
| Q37690726 | Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway |
| Q28593590 | Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2) |
| Q30356087 | Development of a Whole Organism Platform for Phenotype-Based Analysis of IGF1R-PI3K-Akt-Tor Action. |
| Q26999279 | Developments in renal pharmacogenomics and applications in chronic kidney disease |
| Q35947790 | Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin |
| Q28550290 | Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium |
| Q35790313 | Dietary fructose inhibits lactation-induced adaptations in rat 1,25-(OH)₂D₃ synthesis and calcium transport |
| Q58791444 | Dietary vitamin D supplementation protects laying hens against lipopolysaccharide-induced immunological stress |
| Q38048501 | Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations |
| Q41886049 | Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease |
| Q26741417 | Disruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin Cancer |
| Q90230894 | Early Rehabilitation Program and Vitamin D Supplementation Improves Sensitivity of Balance and the Postural Control in Patients after Posterior Lumbar Interbody Fusion: A Randomized Trial |
| Q64229510 | Effect of Vitamin D Supplement on Mood Status and Inflammation in Vitamin D Deficient Type 2 Diabetic Women with Anxiety: A Randomized Clinical Trial |
| Q35038553 | Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells |
| Q40048028 | Effects of Vitamin D Supplementation on Carotid Intima-Media Thickness in HIV-infected Youth |
| Q38066985 | Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review |
| Q35780832 | Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study |
| Q43198337 | Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts |
| Q27006548 | Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms |
| Q35929897 | Expression of MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells |
| Q35958335 | Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation |
| Q36487466 | Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression |
| Q35239437 | Genetic and environmental factors are associated with serum 25-hydroxyvitamin D concentrations in older African Americans |
| Q37883044 | Genetics of interleukin 1 receptor-like 1 in immune and inflammatory diseases |
| Q36544557 | Genome-wide approaches for identification of nuclear receptor target genes |
| Q55379615 | Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. |
| Q37374239 | Genomic tools for dissecting oncogenic transcriptional networks in human leukemia |
| Q34005554 | Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells. |
| Q47797228 | HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis |
| Q48231846 | High prevalence of vitamin D deficiency and insufficiency in adolescent inpatients diagnosed with eating disorders |
| Q46276830 | Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice |
| Q38768967 | Hypothalamic Vitamin D Improves Glucose Homeostasis and Reduces Weight |
| Q47284583 | Identification of Genotypes and Allelic Frequencies of Vitamin D Receptor Gene Polymorphism (TaqI) in Egyptian Melasma Patients |
| Q26751406 | Immune oxysterols: Role in mycobacterial infection and inflammation |
| Q33827416 | Immunostimulation in the era of the metagenome |
| Q37725587 | Impact of vitamin D on immune function: lessons learned from genome-wide analysis |
| Q36718441 | Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist |
| Q24617282 | Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region |
| Q34634237 | Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial |
| Q98289831 | Inhibition of HAS2 and hyaluronic acid production by 1,25-Dihydroxyvitamin D3 in breast cancer |
| Q41969311 | Integrative network-based analysis of mRNA and microRNA expression in 1,25-dihydroxyvitamin D3-treated cancer cells |
| Q57027399 | Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses |
| Q42255026 | LncRNA: a new player in 1α, 25(OH)(2) vitamin D(3) /VDR protection against skin cancer formation |
| Q37779281 | Local RAS. |
| Q107547858 | Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms |
| Q34263578 | Long-term vitamin D3 supplementation does not prevent colonic inflammation or modulate bone health in IL-10 knockout mice at young adulthood |
| Q36922503 | Low vitamin D status is associated with more depressive symptoms in Dutch older adults. |
| Q35167841 | Low vitamin D status throughout life results in an inflammatory prone status but does not alter bone mineral or strength in healthy 3-month-old CD-1 male mice |
| Q36050928 | Low-dose oral cholecalciferol is associated with higher numbers of Helios(+) and total Tregs than oral calcitriol in renal allograft recipients: an observational study |
| Q61449001 | Lower vitamin D levels are associated with depression in patients with gout |
| Q34275669 | Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes |
| Q28513722 | Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene |
| Q90065922 | Maternal Vitamin D Deficiency Causes Sustained Impairment of Lung Structure and Function and Increases Susceptibility to Hyperoxia-Induced Lung Injury in Infant Rats |
| Q37921173 | Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment |
| Q36471410 | Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells |
| Q37254347 | Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators? |
| Q37125368 | Menthol Enhances an Antiproliferative Activity of 1alpha,25-Dihydroxyvitamin D(3) in LNCaP Cells |
| Q27693209 | Modeling vitamin D actions in triple negative/basal-like breast cancer |
| Q24654260 | Molecular actions of vitamin D contributing to cancer prevention |
| Q38317775 | Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes |
| Q26741117 | Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease |
| Q46157192 | Multivitamin supplementation of Wistar rats during pregnancy accelerates the development of obesity in offspring fed an obesogenic diet |
| Q60046972 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity |
| Q50204183 | Mycobacterial r32-kDa antigen-specific T-cell responses correlate with successful treatment and a heightened anti-microbial response in human leprosy patients |
| Q39979826 | Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase |
| Q48109339 | Narrow-band UVB effects on cutaneous vitamin D receptor expression and serum 25-hydroxyvitamin D in generalized vitiligo. |
| Q89820420 | Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity |
| Q59336778 | No Association between Polymorphisms of Vitamin D and Oxytocin Receptor Genes and Autistic Spectrum Disorder in a Sample of Turkish Children |
| Q35620895 | Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy |
| Q37726333 | Nuclear receptor repression: regulatory mechanisms and physiological implications. |
| Q51352830 | Older age and lower adiposity predict better 25-hydroxy vitamin D concentration in Inuit adults: International Polar Year Inuit Health Survey, 2007-2008. |
| Q51069588 | PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D. |
| Q38804461 | PTH and Vitamin D. |
| Q38967717 | Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia. |
| Q35161248 | Patterns of genome-wide VDR locations. |
| Q40051941 | Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands |
| Q35838327 | Placental amino acid transport may be regulated by maternal vitamin D and vitamin D-binding protein: results from the Southampton Women's Survey. |
| Q38839819 | Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration. |
| Q28080837 | Plausible ergogenic effects of vitamin D on athletic performance and recovery |
| Q41678972 | Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case-control study |
| Q37974703 | Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D. |
| Q40320613 | Proinflammatory Cytokines Impair Vitamin D-Induced Host Defense in Cultured Airway Epithelial Cells |
| Q91761566 | RETRACTED: TRPV6 calcium channel regulation, downstream pathways, and therapeutic targeting in cancer |
| Q37783496 | Reciprocal Control of 1,25-Dihydroxyvitamin D and FGF23 Formation Involving the FGF23/Klotho System |
| Q48263712 | Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes |
| Q40812164 | Role of Vitamin D deficiency in extraskeletal complications: predictor of health outcome or marker of health status? |
| Q38131033 | Role of vitamin D in the pathogenesis and treatment of atopic dermatitis |
| Q48854619 | Role of vitamin D in the physiopathology of neurodegenerative diseases |
| Q40180361 | Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics |
| Q37581773 | SNP rs11185644 of RXRA gene is identified for dose-response variability to vitamin D3 supplementation: a randomized clinical trial |
| Q21284097 | Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation |
| Q36710174 | Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice |
| Q47664087 | Serum Concentrations of 25-Hydroxyvitamin D and Depression in a General Middle-Aged to Elderly Population in Finland. |
| Q37111446 | Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women |
| Q57470854 | Skeletal and extra-skeletal actions of vitamin D: Current evidence and outstanding questions |
| Q39150840 | Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling. |
| Q34178135 | Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor |
| Q36064572 | Systems analysis of the prostate transcriptome in African-American men compared with European-American men. |
| Q93003715 | TGF-β1 Impairs Vitamin D-Induced and Constitutive Airway Epithelial Host Defense Mechanisms |
| Q92383138 | TRPV6 as A Target for Cancer Therapy |
| Q40126939 | TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. |
| Q28477138 | TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth |
| Q40123571 | TRPV6 is a Ca2+ entry channel essential for Ca2+-induced differentiation of human keratinocytes. |
| Q35285791 | TSLP is differentially regulated by vitamin D3 and cytokines in human skin |
| Q61811251 | The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis |
| Q90449164 | The Influence of Nutrients on Inflammatory Bowel Diseases |
| Q91715276 | The Modulatory Action of Vitamin D on the Renin-Angiotensin System and the Determination of Hepatic Insulin Resistance |
| Q24319095 | The Orosomucoid 1 protein is involved in the vitamin D - mediated macrophage de-activation process |
| Q92238826 | The Vitamin D Binding Protein and Inflammatory Injury: A Mediator or Sentinel of Tissue Damage? |
| Q90053020 | The Vitamin D Receptor Gene Polymorphisms in Asthmatic Children: A Case-Control Study |
| Q91081280 | The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients |
| Q38128592 | The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications. |
| Q41991904 | The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits. |
| Q64937008 | The immunological implication of the new vitamin D metabolism. |
| Q35914728 | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controll |
| Q92052257 | The mTOR Signaling Pathway Activity and Vitamin D Availability Control the Expression of Most Autism Predisposition Genes |
| Q30388273 | The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells. |
| Q36409061 | The problems of vitamin d insufficiency in older people |
| Q37112531 | The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults |
| Q42021323 | The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3. |
| Q40375467 | The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. |
| Q37138526 | The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes |
| Q34396348 | The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers |
| Q55361946 | The vitamin D receptor and the etiology of RANTES/CCL-expressive fatty-degenerative osteolysis of the jawbone: an interface between osteoimmunology and bone metabolism. |
| Q36596696 | The vitamin D receptor as a therapeutic target |
| Q37138638 | The vitamin D receptor in cancer |
| Q33806485 | The vitamin D receptor: a tumor suppressor in skin. |
| Q36332065 | The vitamin D3 transcriptomic response in skin cells derived from the Atlantic bottlenose dolphin. |
| Q36285918 | Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine |
| Q28255158 | Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis |
| Q39940985 | Transcription factors Sp1 and C/EBP regulate NRAMP1 gene expression |
| Q34623118 | Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. |
| Q64899725 | Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity. |
| Q27314765 | Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression |
| Q36918639 | Very important pharmacogene summary for VDR. |
| Q36038824 | Vitamin D Deficiency and Hashimoto's Thyroiditis in Children and Adolescents: a Critical Vitamin D Level for This Association? |
| Q47555888 | Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease |
| Q36376862 | Vitamin D Receptor Expression in Vitiligo |
| Q45071253 | Vitamin D Receptor Signaling and Cancer |
| Q28073157 | Vitamin D Status and Its Consequences for Health in South Africa |
| Q35804575 | Vitamin D Status and VDR Genotype in NF1 Patients: A Case-Control Study from Southern Brazil |
| Q37155378 | Vitamin D Status: Current Opinion on Critical Levels for Plasma Calcium and Bone Mineral Homeostasis |
| Q39155786 | Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirus |
| Q36187597 | Vitamin D and asthma. |
| Q47247668 | Vitamin D and drug-metabolising enzymes |
| Q36973933 | Vitamin D and human health: lessons from vitamin D receptor null mice. |
| Q24630997 | Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity |
| Q36187575 | Vitamin D and sepsis: An emerging relationship |
| Q33646923 | Vitamin D and the RNA transcriptome: more than mRNA regulation |
| Q27026647 | Vitamin D and the central nervous system |
| Q33527015 | Vitamin D and the skin |
| Q33993788 | Vitamin D and the skin: Physiology and pathophysiology |
| Q36644639 | Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia |
| Q46921354 | Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy |
| Q64235744 | Vitamin D in malaria: more hypotheses than clues |
| Q36633765 | Vitamin D in sepsis: from basic science to clinical impact |
| Q34769278 | Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection |
| Q38841858 | Vitamin D inhibits the growth of and virulence factor gene expression by Porphyromonas gingivalis and blocks activation of the nuclear factor kappa B transcription factor in monocytes |
| Q36639258 | Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease |
| Q37918438 | Vitamin D metabolism and signaling in the immune system |
| Q36071737 | Vitamin D receptor and RXR in the post-genomic era. |
| Q35532076 | Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. |
| Q39416598 | Vitamin D receptor is a novel transcriptional regulator for Axin1. |
| Q36344273 | Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor |
| Q42441596 | Vitamin D receptor, UVR, and skin cancer: a potential protective mechanism |
| Q38307555 | Vitamin D receptor, a tumor suppressor in skin |
| Q26849642 | Vitamin D signaling in myogenesis: potential for treatment of sarcopenia |
| Q35942667 | Vitamin D signaling in the bovine immune system: a model for understanding human vitamin D requirements |
| Q36845164 | Vitamin D signaling, infectious diseases, and regulation of innate immunity |
| Q44396563 | Vitamin D status has a linear association with seasonal infections and lung function in British adults |
| Q33969236 | Vitamin D status is independently associated with plasma glutathione and cysteine thiol/disulphide redox status in adults |
| Q33657136 | Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adults |
| Q92423006 | Vitamin D, Skeletal Muscle Function and Athletic Performance in Athletes-A Narrative Review |
| Q33647013 | Vitamin D, intermediary metabolism and prostate cancer tumor progression |
| Q35773620 | Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection |
| Q42779097 | Vitamin D-mediated induction of innate immunity in gingival epithelial cells |
| Q48277609 | Vitamin D-related genes are subjected to significant de novo mutation burdens in autism spectrum disorder |
| Q35052582 | Vitamin D-responsive SGPP2 variants associated with lung cell expression and lung function |
| Q33759350 | Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy |
| Q51016105 | Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice. |
| Q58757535 | Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications |
| Q38368241 | Vitamin D: Immuno-modulation and tuberculosis treatment |
| Q35588916 | Vitamin D: Implications for ocular disease and therapeutic potential |
| Q37721243 | Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism |
| Q26799314 | Vitamins and Melanoma |
| Q33269869 | Widespread Alu repeat-driven expansion of consensus DR2 retinoic acid response elements during primate evolution |
| Q46275615 | l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)2 D3 -induced myeloid differentiation in acute myeloid leukemia cells |
Search more.